BioSpace News Archive

Biotech Beach

Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma

Eyenuk has been approved to market its EyeArt® AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage (a sign of glaucoma).

January 31, 2023
·
5 min read
Business

Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on Tuesday February 7, 2023Webcast and Conference Call To be Held Tuesday, February 7, 2023, 8:30 am ET

Anavex Life Sciences Corp. today announced that it will issue financial results for its quarter ended December 31, 2022 on Tuesday February 7, 2023.

January 31, 2023
·
3 min read
BioMidwest

Cancer & Hematology Centers of Western Michigan Launches Cancer Drug Donation Program To Turn Unused Medicines Into Free Drug for Qualified Michigan Residents

Cancer & Hematology Centers of Western Michigan (CHCWM) has launched a Cancer Drug Repository (CDR) program to accept qualified unused oral cancer drug donations from individuals so they can be used for free by another Michigan resident who meets specific eligibility criteria described in state law.

January 31, 2023
·
3 min read
Business

Emergent Health Appoints Former Kraft Foods Director of National Accounts Charlie McMenamin to Its Board of Directors

Emergent Health Corp. announced today the appointment of former Kraft Foods Director of National Accounts Charlie McMenamin to its Board of Directors.

January 31, 2023
·
4 min read
BioMidwest

SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

SeaStar Medical announces that Eric Schlorff, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 3:30 p.m. Eastern time.

January 31, 2023
·
1 min read
MedRhythms’ Feasibility Study Shows Positive Topline Results in Parkinson’s Disease

MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset in development for the treatment of gait deficits in Parkinson’s disease (PD).

January 31, 2023
·
4 min read
Business

Biosero and Virscidian Announce Collaboration for Medicinal Chemistry Applications in Drug Discovery

Biosero, Inc. and Virscidian, developer of solutions to automate LC/MS (liquid chromatography and mass spectrometry) decision-driven workflows, today announced a collaboration and co-marketing agreement through which the companies will support fully automated analytical workflows for medicinal chemistry.

January 31, 2023
·
4 min read
Pharm Country

Halberd to Conduct Animal Tests of Nasal Spray that Blocks Negative Effects of Head Trauma

Halberd Corporation (OTC PINK:HALB) confirmed that animal testing at Mississippi State University (MSU) will focus on Halberd’s patent-pending nasal spray to mitigate the effects of Traumatic Brain Injury (TBI), when administered shortly after sustaining a head Injury.

January 31, 2023
·
4 min read
Biotech Bay

Guardant Health introduces Guardant GalaxyTM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery

Guardant Health introduces Guardant Galaxy TM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery.

January 31, 2023
·
5 min read
Pharm Country

Schrödinger to Present at SVB Securities Global Biopharma Conference

Schrödinger today announced that management will participate in the SVB Securities Global Biopharma Conference and will give a presentation on Tuesday, February 14, 2023, at 1:00 p.m. ET.

January 31, 2023
·
1 min read